Your browser doesn't support javascript.
loading
Exploiting the fibroblast growth factor receptor-1 vulnerability to therapeutically restrict the MYC-EZH2-CDKN1C axis-driven proliferation in Mantle cell lymphoma.
Sircar, Anuvrat; Singh, Satishkumar; Xu-Monette, Zijun Y; Coyle, Krysta Mila; Hilton, Laura K; Chavdoula, Evangelia; Ranganathan, Parvathi; Jain, Neeraj; Hanel, Walter; Tsichlis, Philip; Alinari, Lapo; Peterson, Blake R; Tao, Jianguo; Muthusamy, Natarajan; Baiocchi, Robert; Epperla, Narendranath; Young, Ken H; Morin, Ryan; Sehgal, Lalit.
  • Sircar A; Division of Hematology, College of Medicine, The Ohio State University, Columbus, OH, USA.
  • Singh S; The Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH, USA.
  • Xu-Monette ZY; Division of Hematology, College of Medicine, The Ohio State University, Columbus, OH, USA.
  • Coyle KM; The Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH, USA.
  • Hilton LK; Division of Hematopathology, Department of Pathology, Duke University Medical Center, Durham, NC, USA.
  • Chavdoula E; Department of Molecular Biology & Biochemistry, Simon Fraser University, Burnaby, BC, Canada.
  • Ranganathan P; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada.
  • Jain N; The Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH, USA.
  • Hanel W; Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, USA.
  • Tsichlis P; Division of Hematology, College of Medicine, The Ohio State University, Columbus, OH, USA.
  • Alinari L; The Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH, USA.
  • Peterson BR; Division of Cancer Biology, CSIR-Central Drug Research Institute, Lucknow, Uttar Pradesh, 226031, India.
  • Tao J; Academy of Scientific and Innovative Research, Ghaziabad, Uttar Pradesh, 201002, India.
  • Muthusamy N; Division of Hematology, College of Medicine, The Ohio State University, Columbus, OH, USA.
  • Baiocchi R; The Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH, USA.
  • Epperla N; The Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH, USA.
  • Young KH; Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, USA.
  • Morin R; Division of Hematology, College of Medicine, The Ohio State University, Columbus, OH, USA.
  • Sehgal L; The Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH, USA.
Leukemia ; 37(10): 2094-2106, 2023 10.
Article en En | MEDLINE | ID: mdl-37598282

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma de Células del Manto Tipo de estudio: Prognostic_studies Límite: Adult / Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma de Células del Manto Tipo de estudio: Prognostic_studies Límite: Adult / Humans Idioma: En Año: 2023 Tipo del documento: Article